HIGHLIGHTS
- who: Atefeh Khodakarami from the (UNIVERSITY) have published the paper: The molecular biology and therapeutic potential of Nrf2 in leukemia, in the Journal: (JOURNAL)
- what: This study shows the opposite role of Nrf2 compared to previous studies and highlights that activation of this pathway signaling causes a reduction in the risk of liver and lung cancer. This study showed more vital staining of cytoplasmic Nrf2 in most tumors than benign ducts. The main aim in this study is to determine the role of this transcription factor in different types of leukemia and whether Nrf2 would . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.